Modulation of ABCC1 and ABCG2 proteins by ouabain in human breast cancer cells

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• ABCC1 and ABCG2 transporters are implicated in multi-drug resistance (MDR) in cancer chemotherapy.
• Ouabain, a cardiotonic steroid and hormone, is linked to arterial hypertension and may influence transporter expression.

Purpose of the Study:

• To investigate the effects of physiological ouabain concentrations on ABCC1 and ABCG2 expression and activity in human breast cancer cell lines (MCF7 and MDA-MB-231).
• To determine if ouabain influences breast cancer cell proliferation and response to chemotherapy (doxorubicin).

Main Methods:

• Cell viability and proliferation assays were performed on MCF7 and MDA-MB-231 cells treated with varying ouabain concentrations.
• Expression levels of ABCG2 and ABCC1 were analyzed after ouabain treatment.
• ABCC1 activity was assessed in response to ouabain exposure.

Main Results:

• Ouabain exhibited differential effects on cell proliferation: 1 μM reduced MCF7 proliferation, while 10 nM increased MDA-MB-231 proliferation.
• 10 nM ouabain conferred doxorubicin resistance in MCF7 cells but not in MDA-MB-231 cells.
• While transporter expression remained largely unchanged, ABCC1 activity was significantly increased by specific ouabain concentrations (10 mM for MCF7, 1 nM for MDA-MB-231).

Conclusions:

• Physiological ouabain concentrations can modulate breast cancer cell proliferation and drug resistance mechanisms, specifically impacting ABCC1 activity.
• These findings suggest that endogenous ouabain levels may influence individual patient responses to chemotherapy, warranting further investigation.